Evidence map›Paper›PMID 36253531›Full record

ArticleEuropean journal of human genetics : EJHG2023

Biallelic loss of LDB3 leads to a lethal pediatric dilated cardiomyopathy.

Tamara T Koopmann, Yalda Jamshidi, Mohammad Naghibi-Sistani, Heleen M van der Klift, Hassan Birjandi, Zuhair Al-Hassnan, Abdullah Alwadai, Giovanni Zifarelli, Ehsan G Karimiani, Sahar Sedighzadeh and 13 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. 2022: the year that was in the European Journal of Human Genetics.European journal of human genetics : EJHG · 2023
    Article
  11. Article
  12. New year, new genes.European journal of human genetics : EJHG · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 12 institutions in 6 countries.

Tamara T Koopmann *Department of Clinical Genetics/LDGA, Leiden University Medical Center, Leiden, The Netherlands.
Yalda Jamshidi *Genetics Research Centre, Molecular and Clinical Sciences Institute, St George's University of London, London, UK. yjamshid@sgul.ac.uk.ORCID 0000-0003-0151-6482
Mohammad Naghibi-SistaniPediatric & Congenital Cardiology Division, Pediatric Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Heleen M van der KliftDepartment of Clinical Genetics/LDGA, Leiden University Medical Center, Leiden, The Netherlands.
Hassan BirjandiPediatric & Congenital Cardiology Division, Pediatric Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Zuhair Al-HassnanThe Cardiovascular Genetics Program, Centre for Genomic Medicine, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Abdullah AlwadaiPICU Department, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
Giovanni ZifarelliCENTOGENE GmbH, Am Strande 7, 18055, Rostock, Germany.
Ehsan G KarimianiGenetics Research Centre, Molecular and Clinical Sciences Institute, St George's University of London, London, UK.
Sahar SedighzadehDepartment of Biological Sciences, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Amir BahreiniKaryoGen, Isfahan, Iran.
Nayereh NouriKaryoGen, Isfahan, Iran.
Merlene PeterDivision of Genetics, Birth Defects & Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 60611, USA.
Kyoko WatanabeDivision of Cardiology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 60611, USA.
Hermine A van DuyvenvoordeDepartment of Clinical Genetics/LDGA, Leiden University Medical Center, Leiden, The Netherlands.
Claudia A L RuivenkampDepartment of Clinical Genetics/LDGA, Leiden University Medical Center, Leiden, The Netherlands.
Aalbertine K K TeunissenDepartment of Obstetrics and Prenatal Diagnosis, Leiden University Medical Center, Leiden, The Netherlands.
Arend D J Ten HarkelDepartment of Pediatric Cardiology, Willem Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands.
Sjoerd G van DuinenDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Monique C HaakDepartment of Pediatric Cardiology, Willem Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands.
Carlos E PradaDivision of Genetics, Birth Defects & Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 60611, USA.
Gijs W E SantenDepartment of Clinical Genetics/LDGA, Leiden University Medical Center, Leiden, The Netherlands. G.W.E.Santen@lumc.nl.ORCID 0000-0003-1959-3267
Reza MaroofianDepartment of Neuromuscular Disorders, Queen Square Institute of Neurology, University College London, London, UK. r.maroofian@ucl.ac.uk.ORCID 0000-0001-6763-1542
Leiden University Medical Center · NLLurie Children's Hospital · USMashhad University of Medical Sciences · IRSt George's, University of London · GBCentogene (Germany) · DEIsfahan University of Medical Sciences · IRKing Faisal Specialist Hospital & Research Centre · SANorthwestern University · USPrince Sultan University · SAQueen Mary University of London · GBShahid Chamran University of Ahvaz · IRUniversity of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autosomal dominant variants in LDB3 (also known as ZASP), encoding the PDZ-LIM domain-binding factor, have been linked to a late onset phenotype of cardiomyopathy and myofibrillar myopathy in humans. However, despite knockout mice displaying a much more severe phenotype with premature death, bi-allelic variants in LDB3 have not yet been reported. Here we identify biallelic loss-of-function variants in five unrelated cardiomyopathy families by next-generation sequencing. In the first family, we identified compound heterozygous LOF variants in LDB3 in a fetus with bilateral talipes and mild left cardiac ventricular enlargement. Ultra-structural examination revealed highly irregular Z-disc formation, and RNA analysis demonstrated little/no expression of LDB3 protein with a functional C-terminal LIM domain in muscle tissue from the affected fetus. In a second family, a homozygous LDB3 nonsense variant was identified in a young girl with severe early-onset dilated cardiomyopathy with left ventricular non-compaction; the same homozygous nonsense variant was identified in a third unrelated female infant with dilated cardiomyopathy. We further identified homozygous LDB3 frameshift variants in two unrelated probands diagnosed with cardiomegaly and severely reduced left ventricular ejection fraction. Our findings demonstrate that recessive LDB3 variants can lead to an early-onset severe human phenotype of cardiomyopathy and myopathy, reminiscent of the knockout mouse phenotype, and supporting a loss of function mechanism.

Indexed as

CardiomyopathiesCardiomyopathy, DilatedAdaptor Proteins, Signal TransducingAnimalsChildFemaleHumansInfantLIM Domain ProteinsMiceStroke VolumeVentricular Function, LeftAdaptor Proteins, Signal TransducingLDB3 protein, humanLdb3 protein, mouseLIM Domain Proteins

Identifiers

PMID36253531
PMCPMC9823012
OpenAlexW4306377397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.